Case Studies in Cancer
First Edition
12 April 2018
FOCUSES ON THE MOLECULAR UNDERPINNINGS OF DISEASE
The modern diagnosis and treatment of cancer is intricately tied to the molecular underpinnings of disease. Case Studies in Cancer highlights the broad range of malignancies in which known molecular pathways contribute to tumorigenesis as well as susceptibility or resistance to therapy.
CASES FOLLOW A BENCH TO BEDSIDE FRAMEWORK
Every case highlights the relationship between the underlying molecular biology and the disease diagnosis and treatment. A logical, consistent organisation of the cases ensures that the translation from “bench to bedside” is always apparent to the reader.
THE PERFECT COMPANION TO WEINBERG’S THE BIOLOGY OF CANCER
As a clinical complement for The Biology of Cancer, this text gives exposure to the broad biological and clinical spectrum of cancer. It’s aimed at advanced undergraduates, basic science graduate students and researchers who may not otherwise get exposure to the diagnosis and treatment of cancer in patient-centered contexts. First and second year medical students will benefit from the “bench to bedside” approach to better understand the biological rationale behind current treatments.
The modern diagnosis and treatment of cancer is intricately tied to the molecular underpinnings of disease. Case Studies in Cancer highlights the broad range of malignancies in which known molecular pathways contribute to tumorigenesis as well as susceptibility or resistance to therapy.
CASES FOLLOW A BENCH TO BEDSIDE FRAMEWORK
Every case highlights the relationship between the underlying molecular biology and the disease diagnosis and treatment. A logical, consistent organisation of the cases ensures that the translation from “bench to bedside” is always apparent to the reader.
THE PERFECT COMPANION TO WEINBERG’S THE BIOLOGY OF CANCER
As a clinical complement for The Biology of Cancer, this text gives exposure to the broad biological and clinical spectrum of cancer. It’s aimed at advanced undergraduates, basic science graduate students and researchers who may not otherwise get exposure to the diagnosis and treatment of cancer in patient-centered contexts. First and second year medical students will benefit from the “bench to bedside” approach to better understand the biological rationale behind current treatments.
